WeightWatchers stock soars, but its cheap Wegovy knockoff 'is not a sustainable long-term business model'
WW International, known as WeightWatchers, saw its stock soar on new of its new compounded GLP-1 offering. But analysts say ...
WeightWatchers stock price skyrockets on news that it will offer a compounded GLP-1 weight-loss drug like Wegovy
The embattled diet brand said it is adding a compounded weight-loss drug in accordance with FDA rules and manufacturing ...
Weight Watchers Stock Rises 38% On Plan To Sell Obesity Drugs
Shares of Weight Watchers parent company WW International (WW) rose nearly 40% after the company announced plans to begin ...
WeightWatchers to offer compounded version of Novo Nordisk's weight-loss drug
WeightWatchers said on Tuesday it would offer a compounded version of Novo Nordisk's popular obesity drug Wegovy as part of ...
WeightWatchers is getting in on the off-brand weight loss drug game — and selling them cheap
WeightWatchers (WW) announced Tuesday that it is now offering off-brand weight loss drugs for one of the cheapest prices in ...
WeightWatchers to offer compounded version of Wegovy weight-loss drug
WeightWatchers said on Tuesday it would offer a compounded version of Novo Nordisk's popular obesity drug Wegovy as part of ...
The Holy Mess on MSN8d
New Updates! Weight Watchers Changes for 2024
What’s going on with Weight Watchers? With the CEO stepping down, a new body-positive approach, continual app changes, ...
WeightWatchers CEO suddenly quits after push to embrace weight-loss drugs like Ozempic, Wegovy
Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.
WeightWatchers cashes in on popularity of weight loss drugs with compounded semaglutide
WW International (NASDAQ:WW), more commonly known as WeightWatchers, will now offer compounded semaglutide to its ...
KELO2d
WeightWatchers adds compounded version of Novo’s obesity drug to weight-loss program
WeightWatchers said on Tuesday it would offer compounded form of Novo Nordisk's popular obesity drug Wegovy as part of its ...
New York Post13d
WeightWatchers CEO suddenly quits after push to embrace weight-loss drugs like Ozempic, Wegovy
WeightWatchers CEO Sima Sistani abruptly stepped down Friday after a two-year stint that included a controversial embrace of weight-loss drugs like Ozempic and Wegovy. Sistani pushed the 61-year ...
Hosted on MSN1d
WeightWatchers (NASDAQ:WW) Stock Jumps 40% on Plan to Sell Obesity Medications
Shares of WeightWatchers parent company WW International ($WW) have rocketed 40% higher on news that the company plans to ...